XML 21 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities:    
Net income (loss) $ 26,955 $ (44,941)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation, depletion and amortization 40,102 27,147
Amortization of debt discount and issuance costs 3,351 3,197
Non-cash employee stock compensation expense 4,144 4,227
Tax benefit of stock-based compensation exercises 24 150
Deferred tax expense (1,030) 11,767
Other (153) (390)
Changes in assets and liabilities:    
Royalty receivables (5,962) 13,142
Stream inventory (3,125) (1,981)
Income taxes receivable (16,480) (17,192)
Prepaid expenses and other assets (1,724) (2,682)
Accounts payable 1,777 3,266
Uncertain tax positions 6,374 77
Other liabilities 879 6,704
Net cash provided by operating activities 55,132 2,491
Cash flows from investing activities:    
Acquisition of stream and royalty interests (90,083) (1,300,881)
Andacollo royalty termination   345,000
Golden Star term loan   (20,000)
Other (226) (228)
Net cash used in investing activities (90,309) (976,109)
Cash flows from financing activities:    
Borrowings from revolving credit facility 70,000 350,000
Net payments from issuance of common stock (2,038)  
Common stock dividends (15,012) (14,341)
Purchase of additional royalty interest from non-controlling interest (1,025)  
Tax expense of stock-based compensation exercises (24) (150)
Other (315) (430)
Net cash provided by financing activities 51,586 335,079
Net increase (decrease) in cash and equivalents 16,409 (638,539)
Cash and equivalents at beginning of period 116,633 742,849
Cash and equivalents at end of period $ 133,042 $ 104,310